Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Office of Minority Health and Health Disparities Research, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Campus, Washington, DC, USA.
J Natl Cancer Inst. 2021 Jun 1;113(6):710-718. doi: 10.1093/jnci/djaa188.
The causes of racial disparities in epithelial ovarian cancer (EOC) incidence remain unclear. Differences in the prevalence of ovarian cancer risk factors may explain disparities in EOC incidence among African American (AA) and White women.
We used data from 4 case-control studies and 3 case-control studies nested within prospective cohorts in the Ovarian Cancer in Women of African Ancestry Consortium to estimate race-specific associations of 10 known or suspected EOC risk factors using logistic regression. Using the Bruzzi method, race-specific population attributable risks (PAR) were estimated for each risk factor individually and collectively, including groupings of exposures (reproductive factors and modifiable factors). All statistical tests were 2-sided.
Among 3244 White EOC cases and 9638 controls and 1052 AA EOC cases and 2410 controls, AA women had a statistically significantly higher PAR (false discovery rate [FDR] P < .001) for first-degree family history of breast cancer (PAR = 10.1%, 95% confidence interval [CI] = 6.5% to 13.7%) compared with White women (PAR = 2.6%, 95% CI = 0.8% to 4.4%). After multiple test correction, AA women had a higher PAR than White women when evaluating all risk factors collectively (PAR = 61.6%, 95% CI = 48.6% to 71.3% vs PAR = 43.0%, 95% CI = 32.8% to 51.4%, respectively; FDR P = .06) and for modifiable exposures, including body mass index, oral contraceptives, aspirin, and body powder (PAR = 36.0%, 95% CI = 21.0% to 48.8% vs PAR = 13.8%, 95% CI = 4.5% to 21.8%, respectively; FDR P = .04).
Collectively, the selected risk factors accounted for slightly more of the risk among AA than White women, and interventions to reduce EOC incidence that are focused on multiple modifiable risk factors may be slightly more beneficial to AA women than White women at risk for EOC.
上皮性卵巢癌(EOC)发病率的种族差异的原因尚不清楚。卵巢癌危险因素的流行率差异可能解释了非裔美国(AA)和白人妇女之间 EOC 发病率的差异。
我们使用了来自非洲裔美国妇女卵巢癌联盟中的 4 项病例对照研究和 3 项嵌套于前瞻性队列研究中的病例对照研究的数据,使用逻辑回归估计了 10 种已知或可疑的 EOC 危险因素在 AA 和白人妇女中的种族特异性关联。使用布鲁齐方法,分别和总体上估计了每个危险因素的种族特异性人群归因风险(PAR),包括暴露因素(生殖因素和可改变因素)的分组。所有统计检验均为双侧检验。
在 3244 例白人 EOC 病例和 9638 例对照以及 1052 例 AA EOC 病例和 2410 例对照中,与白人妇女(PAR=2.6%,95%置信区间[CI]为 0.8%至 4.4%)相比,AA 妇女的一级乳腺癌家族史的 PAR(假发现率[FDR]P<.001)具有统计学意义更高(PAR=10.1%,95%CI 为 6.5%至 13.7%)。经过多次检验校正后,当评估所有危险因素的总体情况时,AA 妇女的 PAR 高于白人妇女(PAR=61.6%,95%CI 为 48.6%至 71.3% vs PAR=43.0%,95%CI 为 32.8%至 51.4%;FDR P=.06),并且对于可改变的暴露因素,包括体重指数、口服避孕药、阿司匹林和体粉(PAR=36.0%,95%CI 为 21.0%至 48.8% vs PAR=13.8%,95%CI 为 4.5%至 21.8%;FDR P=.04)。
总体而言,选定的危险因素在 AA 妇女中占比略高于白人妇女,而针对多个可改变危险因素的降低 EOC 发病率的干预措施可能对有 EOC 风险的 AA 妇女比白人妇女更为有益。